| 000 | 03329cam a2200805 i 4500 | ||
|---|---|---|---|
| 001 | ocn910720322 | ||
| 003 | OCoLC | ||
| 005 | 20171024111653.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 130206s2013 enk sb 001 0 eng | ||
| 010 | _a 2013005181 | ||
| 020 | _a9781118312056 ( ePub) | ||
| 020 | _a1118312058 ( ePub) | ||
| 020 | _a9781118312063 (MobiPocket) | ||
| 020 | _a1118312066 (MobiPocket) | ||
| 020 | _a9781118312131 (Adobe PDF) | ||
| 020 | _a1118312139 (Adobe PDF) | ||
| 020 | _z9781118312155 (cloth) | ||
| 020 | _a9781118312087 | ||
| 020 | _a1118312082 | ||
| 029 | 1 |
_aNZ1 _b15341511 |
|
| 029 | 1 |
_aDKDLA _b820120-katalog:000664376 |
|
| 029 | 1 |
_aDEBBG _bBV042795505 |
|
| 029 | 1 |
_aGBVCP _b790209187 |
|
| 029 | 1 |
_aDEBBG _bBV043397857 |
|
| 035 |
_a(OCoLC)910720322 _z(OCoLC)827010652 |
||
| 040 |
_aDLC _beng _cDLC _dMHW _dN$T _dYDXCP _dDG1 _dCUI _dSTF _dOCLCF _dNLGGC _dVLB _dEBLCP _dOCLCQ _dDEBBG _dD6H |
||
| 042 | _apcc | ||
| 049 | _aMAIN | ||
| 050 | 0 | 0 | _aRJ560 |
| 060 | 1 | 0 | _aQV 771 |
| 072 | 7 |
_aMED _x023000 _2bisacsh |
|
| 072 | 7 |
_aMED _x058170 _2bisacsh |
|
| 072 | 7 |
_aMED _x071000 _2bisacsh |
|
| 072 | 7 |
_aMED _x072000 _2bisacsh |
|
| 082 | 0 | 0 |
_a615/.190083 _223 |
| 245 | 0 | 0 |
_aPediatric drug development :concepts and applications / _c[edited by] Andrew E. Mulberg, Dianne Murphy, Julia Dunne, Lisa L. Mathis. _h[electronic resource] |
| 250 | _aSecond edition. | ||
| 264 | 1 |
_aChichester, West Sussex, UK : _bWiley Blackwell, _c2013. |
|
| 300 | _a1 online resource. | ||
| 336 |
_atext _2rdacontent |
||
| 337 |
_acomputer _2rdamedia |
||
| 338 |
_aonline resource _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 520 | _aPediatric Drug Development, Second Edition, encompasses the new regulatory initiatives across EU, US and ROW designed to encourage improved access to safe and effective medicines for children. It includes new developments in biomarkers and surrogate endpoints, developmental pharmacology and other novel aspects of pediatric drug development. | ||
| 588 | _aDescription based on print version record and CIP data provided by publisher. | ||
| 650 | 0 | _aPediatric pharmacology. | |
| 650 | 0 | _aDrug development. | |
| 650 | 7 |
_aMEDICAL _xDrug Guides. _2bisacsh |
|
| 650 | 7 |
_aMEDICAL _xNursing _xPharmacology. _2bisacsh |
|
| 650 | 7 |
_aMEDICAL _xPharmacology. _2bisacsh |
|
| 650 | 7 |
_aMEDICAL _xPharmacy. _2bisacsh |
|
| 650 | 7 |
_aDrug development. _2fast _0(OCoLC)fst00898670 |
|
| 650 | 7 |
_aPediatric pharmacology. _2fast _0(OCoLC)fst01056473 |
|
| 650 | 2 | _aChild. | |
| 650 | 2 |
_aDrug Evaluation _xmethods. |
|
| 650 | 2 | _aAge Factors. | |
| 650 | 2 |
_aClinical Trials as Topic _xstandards. |
|
| 650 | 2 |
_aDrug Evaluation _xethics. |
|
| 650 | 2 |
_aDrug Evaluation _xstandards. |
|
| 655 | 4 | _aElectronic books. | |
| 700 | 1 |
_aMulberg, Andrew E., _eeditor of compilation. |
|
| 700 | 1 |
_aMurphy, M. Dianne, _eeditor of compilation. |
|
| 700 | 1 |
_aDunne, Julia, _d1954- _eeditor of compilation. |
|
| 700 | 1 |
_aMathis, Lisa L., _eeditor of compilation. |
|
| 776 | 0 | 8 |
_iPrint version: _tPediatric drug development _bSecond edition. _dChichester, West Sussex : John Wiley & Sons Inc., 2013 _z9781118312155 _w(DLC) 2013004158 |
| 856 | 4 | 0 |
_uhttp://onlinelibrary.wiley.com/book/10.1002/9781118312087 _zWiley Online Library |
| 942 |
_2ddc _cBK |
||
| 999 |
_c208065 _d208065 |
||